[Evaluation of the therapeutic effect of hyperbaric oxygenation and anginin in peptic ulcer].
Hyperbaric oxygenation (HBO) and pyridinolcarbamat were mainly applied in the treatment of elderly patients with peptic ulcer attended by coronary heart disease and atherosclerosis. To evaluate the condition of intracellular regulators after the treatment, a study was made of the time-course of changes in the content of cyclic nucleotides in blood plasma and gastric mucosa. The use of HBO in the treatment of peptic ulcer raised the efficacy of the multimodality therapy and accelerated the epithelization of erosive and ulcerative defects. The use of pyridinolcarbamat turned to produce a beneficial therapeutic effect and to be protective with respect to the gastric mucosa. Thus it was found desirable to apply the drug to the treatment of ulcers mainly occurring in the stomach. The changes in the content of cyclic nucleotides in blood plasma and gastric mucosa may play an important role in the realization of positive metabolic changes in gastric mucosa, induced by pyridinolcarbamat and HBO in peptic ulcer patients.
Elizavetina
G A
GA
Vinnitskiĭ
L I
LI
Vorob'eva
N T
NT
Chorbinskaia
S A
SA
Izmalkova
N M
NM
D000368:Aged; D000897:Anti-Ulcer Agents; D002219:Carbamates / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism*; D006801:Humans; D006931:Hyperbaric Oxygenation; D000860:Hypoxia / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000378:metabolism / Q000628:therapy*; D011727:Pyridinolcarbamate / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D002219:Carbamates; D011727:Pyridinolcarbamate; D000242:Cyclic AMP; D006152:Cyclic GMP
Otsenka terapevticheskogo éffekta giperbaricheskoĭ oksigenatsii i anginina pri iazvennoĭ bolezni zheludka i dvenadtsatiperstnoĭ kishki.